Compare Stocks

→ Start loving Mondays like this (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARDMQ Aradigm	$0.05	$0.05	$0.02 ▼ $0.20	$764K	N/A	21,923 shs	N/A
MAGAA Magna-Lab	$0.95	$0.63	$0.11 ▼ $2.00	$1.12M	7.51	3,117 shs	N/A
NXNN Nexeon Medsystems		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences		$0.00	$2.91 ▼ $82.80	$1.90M	2.03	1,362 shs	6,500 shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARDMQ Aradigm	0.00%	0.00%	0.00%	0.00%	0.00%
MAGAA Magna-Lab	0.00%	-0.78%	+192.31%	+216.67%	+968.62%
NXNN Nexeon Medsystems	0.00%	0.00%	0.00%	0.00%	-99.93%
RSLSD ReShape Lifesciences	0.00%	0.00%	0.00%	0.00%	0.00%

A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARDMQ Aradigm	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MAGAA Magna-Lab	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARDMQ Aradigm	N/A	N/A	N/A	N/A
MAGAA Magna-Lab	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARDMQ Aradigm	N/A	N/A	N/A	N/A	N/A	N/A
MAGAA Magna-Lab	N/A	N/A	N/A	N/A	($1.52) per share	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	$610K	0.00	N/A	0.08	$341.84 per share	0.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARDMQ Aradigm	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MAGAA Magna-Lab	-$130K	$0.18	5.28	∞	N/A	N/A	-12.32%	42,399.99%	N/A
NXNN Nexeon Medsystems	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	-$81.15M	N/A	0.00	N/A	N/A	-668.58%	-163.22%	-52.10%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARDMQ Aradigm	N/A	N/A	N/A	N/A	N/A
MAGAA Magna-Lab	N/A	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARDMQ Aradigm	N/A	N/A	N/A
MAGAA Magna-Lab	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A
RSLSD ReShape Lifesciences	0.05	1.17	1.07

Ownership

Institutional Ownership

Company	Institutional Ownership
ARDMQ Aradigm	N/A
MAGAA Magna-Lab	N/A
NXNN Nexeon Medsystems	N/A
RSLSD ReShape Lifesciences	N/A

Insider Ownership

Company	Insider Ownership
ARDMQ Aradigm	4.50%
MAGAA Magna-Lab	15.30%
NXNN Nexeon Medsystems	61.19%
RSLSD ReShape Lifesciences	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ARDMQ Aradigm	N/A	15.28 million	N/A	Not Optionable
MAGAA Magna-Lab	N/A	1.18 million	N/A	Not Optionable
NXNN Nexeon Medsystems	62	N/A	N/A	Not Optionable
RSLSD ReShape Lifesciences	43	354,000	N/A	Not Optionable

MAGAA, NXNN, ARDMQ, and RSLSD Headlines

Source	Headline
	ReShape Lifesciences (OTCMKTS:RSLSD) Stock Price Up 2.3% americanbankingnews.com - April 9 at 2:16 AM
	Insider Selling: STANKOVICH THOMAS, ReShape Lifesciences Inc. [RSLS] Chief Financial Officer divested 106 shares knoxdaily.com - November 2 at 5:17 PM
	ReShape Lifesciences (NASDAQ: RSLS) up 60% - But why in the name of….? dhakatribune.com - October 27 at 2:21 PM
	ReShape Lifesciences Inc. [RSLS] Shares Fall Approximately -98.23% Over the Year knoxdaily.com - October 12 at 3:16 PM
	ReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon System finanznachrichten.de - September 21 at 10:10 AM
	ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System finance.yahoo.com - September 21 at 10:10 AM
	Recent Insider Activity Could Benefit ReShape Lifesciences Inc. (RSLS) knoxdaily.com - June 29 at 11:06 PM
	ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0 finance.yahoo.com - June 26 at 5:52 PM
	Potential Price Increase for ReShape Lifesciences Inc. (RSLS) After Recent Insider Activity knoxdaily.com - June 19 at 7:45 PM
	ReShape Lifesciences® to Participate in Investor and Industry Conferences in June finance.yahoo.com - June 14 at 8:57 AM
	ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call Transcript insidermonkey.com - May 17 at 5:09 PM
	ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 Diabetes markets.buffalonews.com - April 27 at 9:54 AM
	ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market finance.yahoo.com - April 20 at 10:16 AM
	ReShape Lifesciences(R) Receives Notice of Allowance for U.S. Patent Related to its Obalon(R) Balloon System marketwatch.com - April 12 at 3:13 PM
	ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to its Obalon® Balloon System finance.yahoo.com - April 11 at 9:04 AM
	ReShape Lifesciences postpones earnings release seekingalpha.com - March 31 at 4:37 PM
	Earnings Outlook For Reshape Lifesciences msn.com - March 28 at 2:08 PM
	ReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public Offering benzinga.com - February 8 at 12:59 PM
	Why Is Reshape Lifesciences (RSLS) Stock Up 136% Today? msn.com - February 3 at 8:23 AM
	ReShape Lifesciences Inc. (RSLS) Q3 2022 Earnings Call Transcript seekingalpha.com - November 14 at 1:46 PM
	ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update yahoo.com - November 14 at 8:46 AM
	ReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device ... bakersfield.com - November 5 at 11:22 PM
	ReShape Lifesciences to Present at the Q4 Investor Summit benzinga.com - November 2 at 7:19 PM
	ReShape Lifesciences(TM) Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device stockhouse.com - September 24 at 1:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aradigm

OTCMKTS:ARDMQ

Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

Magna-Lab

OTCMKTS:MAGAA

Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.

Nexeon Medsystems

OTCMKTS:NXNN

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

ReShape Lifesciences

OTCMKTS:RSLSD

ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial